PL1970060T3 - Zastosowanie związków C-(2-fenylocykloheksylo)-metylo-aminowych do terapii fibromyalgii - Google Patents
Zastosowanie związków C-(2-fenylocykloheksylo)-metylo-aminowych do terapii fibromyalgiiInfo
- Publication number
- PL1970060T3 PL1970060T3 PL08008351T PL08008351T PL1970060T3 PL 1970060 T3 PL1970060 T3 PL 1970060T3 PL 08008351 T PL08008351 T PL 08008351T PL 08008351 T PL08008351 T PL 08008351T PL 1970060 T3 PL1970060 T3 PL 1970060T3
- Authority
- PL
- Poland
- Prior art keywords
- cyclohexyl
- dimethylaminomethyl
- phenol
- methoxyphenyl
- phenyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Child & Adolescent Psychology (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10356362A DE10356362A1 (de) | 2003-11-28 | 2003-11-28 | Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie von Angststörungen |
| EP08008351A EP1970060B9 (de) | 2003-11-28 | 2004-11-26 | Verwendung von C-(2-Phenyl-cyclohexyl)-methylaminverbindungen zur Therapie von Fibromyalgia |
| EP04819227A EP1686984B1 (de) | 2003-11-28 | 2004-11-26 | Verwendung von c-(2-phenyl-cyclohexyl)-methylaminverbindungen zur therapie von angststörungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1970060T3 true PL1970060T3 (pl) | 2012-11-30 |
Family
ID=34609453
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04819227T PL1686984T3 (pl) | 2003-11-28 | 2004-11-26 | Zastosowanie związków C-(2-fenylocykloheksylo)-metyloaminowych do terapii zaburzeń lękowych |
| PL08008351T PL1970060T3 (pl) | 2003-11-28 | 2004-11-26 | Zastosowanie związków C-(2-fenylocykloheksylo)-metylo-aminowych do terapii fibromyalgii |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04819227T PL1686984T3 (pl) | 2003-11-28 | 2004-11-26 | Zastosowanie związków C-(2-fenylocykloheksylo)-metyloaminowych do terapii zaburzeń lękowych |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US20060258741A1 (pl) |
| EP (2) | EP1686984B1 (pl) |
| JP (1) | JP5013875B2 (pl) |
| AT (1) | ATE509626T1 (pl) |
| CA (1) | CA2546672C (pl) |
| CY (2) | CY1113348T1 (pl) |
| DE (1) | DE10356362A1 (pl) |
| DK (2) | DK1686984T3 (pl) |
| ES (2) | ES2362752T3 (pl) |
| HR (1) | HRP20110608T1 (pl) |
| PL (2) | PL1686984T3 (pl) |
| PT (2) | PT1970060E (pl) |
| SI (2) | SI1970060T1 (pl) |
| WO (1) | WO2005051375A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050182131A1 (en) * | 2002-07-19 | 2005-08-18 | Gruenenthal Gmbh | 1-Phenyl-2-dimethylaminomethyl cyclohexane compounds and therapies for depressive symptoms, pain and incontinence |
| DE102005034974A1 (de) * | 2005-07-22 | 2007-04-19 | Grünenthal GmbH | Salz von Dimethylaminomethyl-phenyl-cyclohexan und dessen kristalline Formen |
| DE102005034973A1 (de) * | 2005-07-22 | 2007-02-15 | Grünenthal GmbH | Salz von Dimethylaminomethyl-phenyl-cyclohexan und dessen kristalline Formen |
| DE102005061428A1 (de) * | 2005-12-22 | 2007-08-16 | Grünenthal GmbH | Substituierte Cyclohexylmethyl-Derivate |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19525137C2 (de) | 1995-07-11 | 2003-02-27 | Gruenenthal Gmbh | 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe |
| US6387956B1 (en) * | 1999-03-24 | 2002-05-14 | University Of Cincinnati | Methods of treating obsessive-compulsive spectrum disorders |
| DE10059411A1 (de) * | 2000-11-30 | 2002-06-13 | Gruenenthal Gmbh | Verwendung von 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur Therapie der Harninkontinenz |
| DE10109763A1 (de) * | 2001-02-28 | 2002-09-05 | Gruenenthal Gmbh | Pharmazeutische Salze |
| DE10146275A1 (de) * | 2001-09-18 | 2003-04-24 | Gruenenthal Gmbh | Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz |
| WO2003048113A1 (en) * | 2001-11-30 | 2003-06-12 | Sepracor Inc. | Tramadol analogs and uses thereof |
| DE10233048A1 (de) * | 2002-07-19 | 2004-01-29 | Grünenthal GmbH | Verwendung von 1-Phenyl-3dimethylamino-propanverbindungen zur Therapie von depressiven Symptomatiken |
| PT1562567T (pt) * | 2002-11-22 | 2017-08-24 | Gruenenthal Gmbh | Combinação de analgésicos selecionados e inibidores da cox-ii |
| DE10254785A1 (de) * | 2002-11-22 | 2004-06-03 | Grünenthal GmbH | Kombination ausgewählter Analgetika mit COX II-Inhibitoren |
| DE102005011517A1 (de) * | 2005-03-10 | 2006-09-21 | Grünenthal GmbH | Transdermales therapeutisches System zur Verabreichung von Analgetika |
| US20090104266A1 (en) * | 2005-09-15 | 2009-04-23 | Tobias Jung | 3-(2-dimethylaminomethylcy clohexyl)phenol retard formulation |
-
2003
- 2003-11-28 DE DE10356362A patent/DE10356362A1/de not_active Ceased
-
2004
- 2004-11-26 DK DK04819227.2T patent/DK1686984T3/da active
- 2004-11-26 SI SI200431926T patent/SI1970060T1/sl unknown
- 2004-11-26 SI SI200431677T patent/SI1686984T1/sl unknown
- 2004-11-26 DK DK08008351.2T patent/DK1970060T3/da active
- 2004-11-26 AT AT04819227T patent/ATE509626T1/de active
- 2004-11-26 WO PCT/EP2004/013439 patent/WO2005051375A1/de active Application Filing
- 2004-11-26 PL PL04819227T patent/PL1686984T3/pl unknown
- 2004-11-26 EP EP04819227A patent/EP1686984B1/de active Active
- 2004-11-26 PL PL08008351T patent/PL1970060T3/pl unknown
- 2004-11-26 ES ES04819227T patent/ES2362752T3/es active Active
- 2004-11-26 PT PT08008351T patent/PT1970060E/pt unknown
- 2004-11-26 PT PT04819227T patent/PT1686984E/pt unknown
- 2004-11-26 ES ES08008351T patent/ES2390931T3/es active Active
- 2004-11-26 CA CA2546672A patent/CA2546672C/en not_active Expired - Fee Related
- 2004-11-26 EP EP08008351A patent/EP1970060B9/de not_active Not-in-force
- 2004-11-26 JP JP2006540395A patent/JP5013875B2/ja not_active Expired - Fee Related
-
2006
- 2006-05-25 US US11/440,005 patent/US20060258741A1/en not_active Abandoned
-
2009
- 2009-09-14 US US12/558,896 patent/US8084497B2/en not_active Expired - Fee Related
-
2010
- 2010-06-09 US US12/797,408 patent/US20100249225A1/en not_active Abandoned
-
2011
- 2011-06-21 CY CY20111100588T patent/CY1113348T1/el unknown
- 2011-08-17 HR HR20110608T patent/HRP20110608T1/hr unknown
-
2012
- 2012-09-28 CY CY20121100904T patent/CY1113162T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1970060B1 (de) | 2012-08-29 |
| HRP20110608T1 (hr) | 2011-10-31 |
| PT1970060E (pt) | 2012-10-02 |
| ES2390931T3 (es) | 2012-11-19 |
| SI1970060T1 (sl) | 2012-10-30 |
| JP5013875B2 (ja) | 2012-08-29 |
| US20100249225A1 (en) | 2010-09-30 |
| EP1970060A3 (de) | 2009-04-15 |
| PL1686984T3 (pl) | 2011-10-31 |
| ATE509626T1 (de) | 2011-06-15 |
| DK1686984T3 (da) | 2011-06-20 |
| EP1686984A1 (de) | 2006-08-09 |
| CA2546672A1 (en) | 2005-06-09 |
| DK1970060T3 (da) | 2012-10-01 |
| ES2362752T3 (es) | 2011-07-12 |
| EP1970060A2 (de) | 2008-09-17 |
| US20060258741A1 (en) | 2006-11-16 |
| JP2007512288A (ja) | 2007-05-17 |
| US20100004341A1 (en) | 2010-01-07 |
| CY1113348T1 (el) | 2016-06-22 |
| DE10356362A1 (de) | 2005-06-23 |
| US8084497B2 (en) | 2011-12-27 |
| EP1970060B9 (de) | 2013-01-09 |
| PT1686984E (pt) | 2011-05-30 |
| SI1686984T1 (sl) | 2011-07-29 |
| CY1113162T1 (el) | 2016-04-13 |
| WO2005051375A1 (de) | 2005-06-09 |
| CA2546672C (en) | 2013-01-22 |
| EP1686984B1 (de) | 2011-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1113162T1 (el) | Χρησιμοποιηση ενωσεων c-(2-φαινυλο-κυκλοεξυλο)-μεθυλαμινης για τη θεραπεια φοβικων διαταραχων | |
| CA2173747C (en) | Calcium receptor-active arylalkyl amines | |
| PL2010531T3 (pl) | Spirocykliczne pochodne cykloheksanu o działaniu przeciwbólowym | |
| JP2882882B2 (ja) | カルシウム受容体活性化合物 | |
| JP2007523955A (ja) | 疾患の治療のためのアミンおよびアミド | |
| MXPA06012505A (es) | Compuestos de morfolina sustituida para el tratamiento de trastornos del sistema nervioso central. | |
| US20070032555A1 (en) | Novel aryloxyphenyl-propanamines | |
| RU2007139543A (ru) | Производные бензодиоксана и бензодиоксолана и их применение | |
| US20090318451A1 (en) | Morpholine dopamine agonists for the treatment of pain | |
| WO2006051378A1 (en) | Substituted n-sulfonylaminobenzyl-2-phenoxy acetamide compounds | |
| JP2012144545A (ja) | アルファ−２−デルタリガンドとセロトニン／ノルアドレナリン再取込み阻害薬を含む組合せ | |
| BG106912A (en) | Diphenyl ether compounds useful in therapy | |
| RU2006107534A (ru) | Комбинация, включающая альфа-2-дельта-лиганд анд и ssri и/или snri, для лечения депрессии и тревожного расстройства | |
| CO5680411A2 (es) | Compuestos del 1-fenil-2-dimetilamino-metil-ciclohexano, para la terapia de sintomatologia depresiva, dolor e incontinencia | |
| JP2014218519A (ja) | ３−フェノキシメチルピロリジン化合物 | |
| JP2006522030A5 (pl) | ||
| JP5714580B2 (ja) | ３−フェノキシメチルピロリジン化合物 | |
| JP2009542819A (ja) | ムスカリン性受容体ｍ１拮抗剤を使用する精神状態の処置 | |
| JP2003523993A5 (pl) | ||
| Andrews et al. | The Discovery of UK-390957: the Challenge of Targeting a Short Half-life, Rapid Tmax SSRI |